Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol
Authors:
- 7 August 2022
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 185, 106996
Abstract
No abstract availableKeywords
Funding Information
- University of Pennsylvania (P50 HD105354)
- National Science Foundation (DGE-1845298)
- Pennsylvania Department of Health
- Children's Hospital of Philadelphia
This publication has 48 references indexed in Scilit:
- Recent Advances in Resting-State Electroencephalography Biomarkers for Autism Spectrum Disorder—A Review of Methodological and Clinical ChallengesPediatric Neurology, 2016
- Cognitive training modifies frequency EEG bands and neuropsychological measures in Rett syndromeResearch in Developmental Disabilities, 2016
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialThe Lancet Neurology, 2016
- Responders to vagus nerve stimulation (VNS) in refractory epilepsy have reduced interictal cortical synchronicity on scalp EEGEpilepsy Research, 2015
- The effect of levetiracetam on focal nocturnal epileptiform activity during sleep — A placebo-controlled double-blind cross-over studyEpilepsy & Behavior, 2012
- The Utility of EEG Band Power Analysis in the Study of Infancy and Early ChildhoodDevelopmental Neuropsychology, 2012
- EEG complexity as a biomarker for autism spectrum disorder riskBMC Medicine, 2011
- Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findingsEpilepsy Research, 2006
- Intraindividual analysis of antiepileptic drug effects on EEG background rhythmsElectroencephalography and Clinical Neurophysiology, 1994
- Effects of Antiepileptic Drug Treatment on the Background Frequency of EEGs in Epileptic PatientsJournal Of Clinical Neurophysiology, 1993